Dermal Fillers
BELOTERO references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
CE Marked
SKU 10091
Belotero Soft Lidocaine
Belotero Soft Lidocaine is an injectable dermal filler designed to restore subtle surface volume to the face. It targets superficial depressions including scars, fine lines, wrinkles and crow’s feet.
In stock
Volume
1x1mL
Laboratory
Merz Aesthetics
Origin
Germany
Indication
Lines, folds and volume correction
Treatment areas
Trade price and history are verified-only
allpara supplies licensed practitioners. Sign in or apply for a B2B account to see live pricing, volume tiers and price history.
Belotero Soft Lidocaine is a sterile, non-pyrogenic, viscoelastic, colourless, transparent cross-linked sodium hyaluronate filler of non-animal origin, supplied in a physiological phosphate buffer and containing 0.3% lidocaine hydrochloride. It is an injectable biodegradable implant for filling of perioral fine lines, with the lidocaine included to reduce local pain associated with injection and to improve patient comfort.
Each 1 mL syringe contains cross-linked sodium hyaluronate 20.0 mg/ml and lidocaine hydrochloride 3.0 mg/ml in phosphate buffer at pH 7. The sodium hyaluronate is produced by fermentation of Streptococcus equi. It is placed in the superficial to mid-dermis and is designed to be injected by authorised practitioners with appropriate training and experience.
ALLPARA supplies Belotero Soft Lidocaine to clinics and licensed practitioners with batch-level traceability and documentation available on request. Wholesale pricing is available to registered professional buyers.
Key Benefits of Belotero Soft Lidocaine
- Injectable biodegradable implant indicated for filling of perioral fine lines
- Cross-linked sodium hyaluronate 20.0 mg/ml with lidocaine hydrochloride 3.0 mg/ml, in phosphate buffer at pH 7
- Indicated for injection into the superficial to mid-dermis, the lightest grade in the range
- Contains 0.3% lidocaine hydrochloride to reduce local pain during injection and improve patient comfort
- Sterile, non-pyrogenic, viscoelastic, colourless and transparent, and of non-animal origin
- Hyaluronate produced by fermentation of Streptococcus equi rather than from an animal source
- Supplied as one 1 mL syringe with two sterile CE-marked single-use needles and two traceability labels
- Manufactured by Anteis SA in Plan-les-Ouates, Geneva, Switzerland, part of the Merz Aesthetics group
- Batch-level traceability on every unit supplied by ALLPARA, with documentation available to professional buyers on request
Indications and Professional Use
Main indications
- Filling of perioral fine lines
- Injection into the superficial to mid-dermis
Professional use
This product is designed to be injected only by authorised healthcare practitioners who have appropriate training and experience and who are qualified or accredited in accordance with national law. It is not for retail sale to consumers and not for self-application. Injection technique, plane, quantity and patient selection are determined by the treating practitioner, and the injection depth is specific to this grade and must not be inherited from another grade in the range.
Treatment areas
- Superficial facial lines
- Fine lines and wrinkles
- Crow's feet
- Superficial facial depressions and certain scar-related irregularities
Patient profile
Suitable for adult patients assessed as appropriate by the treating practitioner. The product is contra-indicated in cases of known hypersensitivity to any of its components, especially sodium hyaluronate, lidocaine hydrochloride, BDDE or other amide-type local anaesthetics; in pregnant and breast-feeding women; in patients under 18 years old; in patients presenting a general infection; and in patients presenting an active auto-immune disease. It must not be injected into blood vessels, into areas presenting cutaneous inflammation or infection of immunological, allergic, bacterial, fungal or viral origin, into an area previously treated with a permanent dermal filler, or into the glabellar or nose region. It must not be used in association with other aesthetic techniques such as peeling, dermabrasion or laser treatment before complete healing of the last treatment, and in no case earlier than two weeks after it. Particular care applies to patients taking anticoagulant, antiplatelet, thrombolytic or anti-inflammatory medication, and to patients pre-disposed to hypertrophic scars or keloids. Patient selection and suitability are determined by the practitioner at consultation.
How Belotero Soft Lidocaine Works
Belotero Soft Lidocaine works through cross-linked sodium hyaluronate, supplied at 20.0 mg/ml with lidocaine hydrochloride 3.0 mg/ml in a physiological phosphate buffer at pH 7, made up to 1 mL. The gel is sterile, non-pyrogenic, viscoelastic, colourless, transparent and of non-animal origin, and acts as an injectable biodegradable implant that increases cutaneous tissue volume where it is placed.
Placement is what defines this grade: it goes into the superficial to mid-dermis for the treatment of perioral fine lines. The lidocaine acts locally during administration to reduce pain associated with injection of the gel and does not alter that mechanism.
Why Order From Allpara
Allpara offers genuine, verified BELOTERO products from vetted suppliers, with full batch-traceability and expert support. We serve clinics and aesthetic professionals with CE-certified products, fast EU-wide delivery from our EU warehouse, and competitive trade pricing. Our focus is your patients' safety, satisfaction and results - with dedicated after-sales support for your peace of mind.
Frequently Asked Questions
Which BELOTERO grade is Belotero Soft Lidocaine?
Belotero Soft Lidocaine is supplied at 20.0 mg/ml cross-linked sodium hyaluronate with lidocaine hydrochloride 3.0 mg/ml, and is placed in the superficial to mid-dermis for perioral fine lines. It is the lightest grade in the range. Belotero Balance Lidocaine is 22.5 mg/ml and covers a wider set of areas, and the two are not interchangeable.
Which treatment areas is Belotero Soft Lidocaine used for?
It is used in the superficial to mid-dermis for the treatment of perioral fine lines. Area selection and placement depth are the treating practitioner's decisions.
More from Merz
RADIESSE references stocked by ALLPARA for professional use, sourced direct and certified on every shipment.
RADIESSE Products
View all 2
Clinic alternatives
/ Recently viewed
Pick up where you left off
Belotero Soft Lidocaine
In stock
CE Marked
Belotero Soft Lidocaine is a sterile, non-pyrogenic, viscoelastic, colourless, transparent cross-linked sodium hyaluronate filler of non-animal origin, supplied in a physiological phosphate buffer and containing 0.3% lidocaine hydrochloride. It is an injectable biodegradable implant for filling of perioral fine lines, with the lidocaine included to reduce local pain associated with injection and to improve patient comfort.
Each 1 mL syringe contains cross-linked sodium hyaluronate 20.0 mg/ml and lidocaine hydrochloride 3.0 mg/ml in phosphate buffer at pH 7. The sodium hyaluronate is produced by fermentation of Streptococcus equi. It is placed in the superficial to mid-dermis and is designed to be injected by authorised practitioners with appropriate training and experience.
ALLPARA supplies Belotero Soft Lidocaine to clinics and licensed practitioners with batch-level traceability and documentation available on request. Wholesale pricing is available to registered professional buyers.
Key Benefits of Belotero Soft Lidocaine
- Injectable biodegradable implant indicated for filling of perioral fine lines
- Cross-linked sodium hyaluronate 20.0 mg/ml with lidocaine hydrochloride 3.0 mg/ml, in phosphate buffer at pH 7
- Indicated for injection into the superficial to mid-dermis, the lightest grade in the range
- Contains 0.3% lidocaine hydrochloride to reduce local pain during injection and improve patient comfort
- Sterile, non-pyrogenic, viscoelastic, colourless and transparent, and of non-animal origin
- Hyaluronate produced by fermentation of Streptococcus equi rather than from an animal source
- Supplied as one 1 mL syringe with two sterile CE-marked single-use needles and two traceability labels
- Manufactured by Anteis SA in Plan-les-Ouates, Geneva, Switzerland, part of the Merz Aesthetics group
- Batch-level traceability on every unit supplied by ALLPARA, with documentation available to professional buyers on request
Indications and Professional Use
Main indications
- Filling of perioral fine lines
- Injection into the superficial to mid-dermis
Professional use
This product is designed to be injected only by authorised healthcare practitioners who have appropriate training and experience and who are qualified or accredited in accordance with national law. It is not for retail sale to consumers and not for self-application. Injection technique, plane, quantity and patient selection are determined by the treating practitioner, and the injection depth is specific to this grade and must not be inherited from another grade in the range.
Treatment areas
- Superficial facial lines
- Fine lines and wrinkles
- Crow's feet
- Superficial facial depressions and certain scar-related irregularities
Patient profile
Suitable for adult patients assessed as appropriate by the treating practitioner. The product is contra-indicated in cases of known hypersensitivity to any of its components, especially sodium hyaluronate, lidocaine hydrochloride, BDDE or other amide-type local anaesthetics; in pregnant and breast-feeding women; in patients under 18 years old; in patients presenting a general infection; and in patients presenting an active auto-immune disease. It must not be injected into blood vessels, into areas presenting cutaneous inflammation or infection of immunological, allergic, bacterial, fungal or viral origin, into an area previously treated with a permanent dermal filler, or into the glabellar or nose region. It must not be used in association with other aesthetic techniques such as peeling, dermabrasion or laser treatment before complete healing of the last treatment, and in no case earlier than two weeks after it. Particular care applies to patients taking anticoagulant, antiplatelet, thrombolytic or anti-inflammatory medication, and to patients pre-disposed to hypertrophic scars or keloids. Patient selection and suitability are determined by the practitioner at consultation.
How Belotero Soft Lidocaine Works
Belotero Soft Lidocaine works through cross-linked sodium hyaluronate, supplied at 20.0 mg/ml with lidocaine hydrochloride 3.0 mg/ml in a physiological phosphate buffer at pH 7, made up to 1 mL. The gel is sterile, non-pyrogenic, viscoelastic, colourless, transparent and of non-animal origin, and acts as an injectable biodegradable implant that increases cutaneous tissue volume where it is placed.
Placement is what defines this grade: it goes into the superficial to mid-dermis for the treatment of perioral fine lines. The lidocaine acts locally during administration to reduce pain associated with injection of the gel and does not alter that mechanism.
Why Order From Allpara
Allpara offers genuine, verified BELOTERO products with full batch-traceability, CE-certified stock, fast EU-wide delivery and expert after-sales support.
Frequently Asked Questions
Which BELOTERO grade is Belotero Soft Lidocaine?
Belotero Soft Lidocaine is supplied at 20.0 mg/ml cross-linked sodium hyaluronate with lidocaine hydrochloride 3.0 mg/ml, and is placed in the superficial to mid-dermis for perioral fine lines. It is the lightest grade in the range. Belotero Balance Lidocaine is 22.5 mg/ml and covers a wider set of areas, and the two are not interchangeable.
Which treatment areas is Belotero Soft Lidocaine used for?
It is used in the superficial to mid-dermis for the treatment of perioral fine lines. Area selection and placement depth are the treating practitioner's decisions.
More from Merz
View laboratory →* Professional-use product. Packaging may vary by batch or market. Refer to the supplied IFU for full directions and contraindications.